Evaluation of patient satisfaction after botulinum toxin A injection for the management of masticatory myofascial pain and dysfunction – A pilot study

References

• Chen YW, Chiu YW, Chen CY, et al. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials. Int J Oral Maxillofac Surg. 2015;44(8):1018–1026.
   PubMed Web of Science ®Google Scholar
• Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord. 1992;6(4):301–355.
   PubMedGoogle Scholar
• Babu NA, Sankari SL, Malathi L. Myofacial pain dysfunction syndrome–a review. Biomed Pharmacol J. 2016;9(2):875–876.
   Google Scholar
• Miernik M, Wieckiewicz M, Paradowska A, et al. Massage therapy in myofascial TMD pain management. Adv Clin Exp Med. 2012;21(5):681–685.
   PubMed Web of Science ®Google Scholar
• Borg-Stein J, Iaccarino MA. Myofascial pain syndrome treatments. Phys Med Rehabil Clin. 2014;25(2):357–374.
   PubMed Web of Science ®Google Scholar
• Mor N, Tang C, Blitzer A. Temporomandibular myofacial pain treated with botulinum toxin injection. Toxins (Basel). 2015;7(8):2791–2800.
   PubMed Web of Science ®Google Scholar
• Ihde SK, Konstantinovic VS. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104(2):e1–e11.
   PubMed Web of Science ®Google Scholar
• Tinastepe N, Küçük BB, Oral K. Botulinum toxin for the treatment of bruxism. CRANIO®. 2015;33(4):291–298.
   Google Scholar
• Sidebottom AJ, Patel AA, Amin J. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study. Br J Oral Maxillofac Surg. 2013;51(3):199–205.
   PubMed Web of Science ®Google Scholar
• Kim HS, Yun PY, Kim YK. A clinical evaluation of botulinum toxin-A injections in the temporomandibular disorder treatment. Maxillofac Plast Reconstr Surg. 2016;38(1):5.
   PubMedGoogle Scholar
• Song P, Schwartz J, Blitzer A. The emerging role of botulinum toxin in the treatment of temporomandibular disorders. Oral Dis. 2007;13(3):253–260.
   PubMed Web of Science ®Google Scholar
• Kurtoglu C, Gur OH, Kurkcu M, et al. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement. J Oral Maxillofac Surg. 2008;66(8):1644–1651.
   PubMed Web of Science ®Google Scholar
• Seedorf H, Leuwer R, Bussopulos A, et al. Influence of botulinum toxin on myogenous facial pain. Schmerz. 2005;19(1):18–25.
   PubMed Web of Science ®Google Scholar
• Magnusson T, List T, Helkimo M. Self‐assessment of pain and discomfort in patients with temporomandibular disorders: a comparison of five different scales with respect to their precision and sensitivity as well as their capacity to register memory of pain and discomfort. J Oral Rehabil. 1995;22(8):549–556.
   PubMed Web of Science ®Google Scholar
• Reed MD, Van Nostran W. Assessing pain intensity with the visual analog scale: a plea for uniformity. J Clin Pharmacol. 2014;54(3):241–244.
   PubMed Web of Science ®Google Scholar
• von Lindern JJ, Niederhagen B, Bergé S, et al. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. J Oral Maxillofac Surg. 2003;61(7):774–778.
   PubMed Web of Science ®Google Scholar
• Kamanli A, Kaya A, Ardicoglu O, et al. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol Int. 2005;25(8):604–611.
   PubMed Web of Science ®Google Scholar
• Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain. 2000;85:101–105.
   PubMed Web of Science ®Google Scholar
• Gül K, Onal S. Comparison of non-invasive and invasive techniques in the treatment of patients with myofascial pain syndrome. Agri. 2009;21(3):104–112.
   PubMedGoogle Scholar
• Filippi GM, Errico P, Santarelli R, et al. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol. 1993;113(3):400–404.
   PubMed Web of Science ®Google Scholar
• Freund B, Schwartz M, Symington J. Botulinum toxin: new treatment for temporomandibular disorders. Br J Oral Maxillofac Surg. 2000;38(5):466–471.
   PubMed Web of Science ®Google Scholar
• Dolly JO, O’Connell MA. Neurotherapeutics to inhibit exocytosis from sensory neurons for the control of chronic pain. Curr Opin Pharmacol. 2012;12(1):100–108.
   PubMed Web of Science ®Google Scholar
• Durham PL, Cady R, Cady R. Regulation of calcitonin gene‐related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache. 2004;44(1):35–43.
   PubMed Web of Science ®Google Scholar
• Intiso D, Basciani M, Santamato A, et al. Botulinum toxin type A for the treatment of neuropathic pain in neuro-rehabilitation. Toxins (Basel). 2015;7(7):2454–2480.
   PubMed Web of Science ®Google Scholar
• Nayyar P, Kumar P, Nayyar PV, et al. Botox: broadening the horizon of dentistry. J Clin Diagn Res. 2014;8(12):ZE25–ZE29.
   PubMedGoogle Scholar
• Dressler D, Benecke R. Pharmacology of therapeutic botulinum toxin preparations. Disabil Rehabil. 2007;29(23):1761–1768.
   PubMed Web of Science ®Google Scholar
• Rafferty KL, Liu ZJ, Ye W, et al. Botulinum toxin in masticatory muscles: short-and long-term effects on muscle, bone, and craniofacial function in adult rabbits. Bone. 2012;50(3):651–662.
   PubMed Web of Science ®Google Scholar
• Kim JY, Kim ST, Cho SW, et al. Growth effects of botulinum toxin type A injected into masseter muscle on a developing rat mandible. Oral Dis. 2008;14(7):626–632.
   PubMed Web of Science ®Google Scholar
• Cavallini M. The setting of a botulinum toxin treatment service. Neurol Sci. 2014;35(1):49–50.
   PubMedGoogle Scholar